Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: Relevance for disease evolution

X. Cabagnols; J. P. Defour; V. Ugo; J. C. Ianotto; P. Mossuz; J. Mondet; F. Girodon; J. H. Alexandre; O. Mansier; J. F. Viallard; E. Lippert; A. Murati; M. J. Mozziconacci; P. Saussoy; M. C. Vekemans; L. Knoops; F. Pasquier; V. Ribrag; E. Solary; I. Plo; S. N. Constantinescu; N. Casadevall; W. Vainchenker; C. Marzac; O. Bluteau

doi:10.1038/leu.2014.270

Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: Relevance for disease evolution

X. Cabagnols, J. P. Defour, V. Ugo, J. C. Ianotto, P. Mossuz, J. Mondet, F. Girodon, J. H. Alexandre, O. Mansier, J. F. Viallard, E. Lippert, A. Murati, M. J. Mozziconacci, P. Saussoy, M. C. Vekemans, L. Knoops, F. Pasquier, V. Ribrag, E. Solary, I. PloS. N. Constantinescu, N. Casadevall, W. Vainchenker, C. Marzac, O. Bluteau

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

86 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	249-252
Nombre de pages	4
journal	Leukemia
Volume	29
Numéro de publication	1
Les DOIs	https://doi.org/10.1038/leu.2014.270
état	Publié - 10 janv. 2015

Accès au document

10.1038/leu.2014.270

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Cabagnols, X., Defour, J. P., Ugo, V., Ianotto, J. C., Mossuz, P., Mondet, J., Girodon, F., Alexandre, J. H., Mansier, O., Viallard, J. F., Lippert, E., Murati, A., Mozziconacci, M. J., Saussoy, P., Vekemans, M. C., Knoops, L., Pasquier, F., Ribrag, V., Solary, E., ... Bluteau, O. (2015). Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: Relevance for disease evolution. Leukemia, 29(1), 249-252. https://doi.org/10.1038/leu.2014.270

@article{27941c958ef24363986bbc1427888d97,

title = "Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: Relevance for disease evolution",

author = "X. Cabagnols and Defour, {J. P.} and V. Ugo and Ianotto, {J. C.} and P. Mossuz and J. Mondet and F. Girodon and Alexandre, {J. H.} and O. Mansier and Viallard, {J. F.} and E. Lippert and A. Murati and Mozziconacci, {M. J.} and P. Saussoy and Vekemans, {M. C.} and L. Knoops and F. Pasquier and V. Ribrag and E. Solary and I. Plo and Constantinescu, {S. N.} and N. Casadevall and W. Vainchenker and C. Marzac and O. Bluteau",

note = "Funding Information: We thank F Fava, C Legrand, I Teyssandier, F Lorre, R Tang and Laboratoire Commun de Biologie et G{\'e}n{\'e}tique Mol{\'e}culaires, AP-HP, h{\^o}pital Saint-Antoine, Drs D Carp, J Dewulf, S Frederic, L Heuberger, I Leduc, F Lefrere, E Legac, E Ronez, J Roussi, C Salanoubat, J-L Vaerman, M Van Butsel, MD Venon, Professor D Latinne and Professor O Legrand for molecular and clinical biology support. This work was supported by grants from la Ligue contre le Cancer (XC, IP, ES WV and OB, {\'e}quipe labellis{\'e}e 2012), from the Agence Nationale de la Recherche (IP, WV ANR Thrombocytosis and GERMPN) and the Laurette Fugain association (WV). XC and OB are supported respectively by grants from the University Paris Diderot and from the ANR. We are grateful for generous support to S.N.C. from the F.R.S.-F.N.R.S., Belgium, the Salus Sanguinis Foundation, the Action de Recherche Concert{\'e}e ARC10/15-027, the Fondation contre le Cancer, Brussels, and the PAI Program Belgian Medical Genetics Initiative Project P7/43 (BeMG) IAP, Belgium.",

year = "2015",

month = jan,

day = "10",

doi = "10.1038/leu.2014.270",

language = "English",

volume = "29",

pages = "249--252",

journal = "Leukemia",

issn = "0887-6924",

number = "1",

}

Cabagnols, X, Defour, JP, Ugo, V, Ianotto, JC, Mossuz, P, Mondet, J, Girodon, F, Alexandre, JH, Mansier, O, Viallard, JF, Lippert, E, Murati, A, Mozziconacci, MJ, Saussoy, P, Vekemans, MC, Knoops, L, Pasquier, F, Ribrag, V, Solary, E, Plo, I, Constantinescu, SN, Casadevall, N, Vainchenker, W, Marzac, C & Bluteau, O 2015, 'Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia: Relevance for disease evolution', Leukemia, VOL. 29, Numéro 1, p. 249-252. https://doi.org/10.1038/leu.2014.270

TY - JOUR

T1 - Differential association of calreticulin type 1 and type 2 mutations with myelofibrosis and essential thrombocytemia

T2 - Relevance for disease evolution

AU - Cabagnols, X.

AU - Defour, J. P.

AU - Ugo, V.

AU - Ianotto, J. C.

AU - Mossuz, P.

AU - Mondet, J.

AU - Girodon, F.

AU - Alexandre, J. H.

AU - Mansier, O.

AU - Viallard, J. F.

AU - Lippert, E.

AU - Murati, A.

AU - Mozziconacci, M. J.

AU - Saussoy, P.

AU - Vekemans, M. C.

AU - Knoops, L.

AU - Pasquier, F.

AU - Ribrag, V.

AU - Solary, E.

AU - Plo, I.

AU - Constantinescu, S. N.

AU - Casadevall, N.

AU - Vainchenker, W.

AU - Marzac, C.

AU - Bluteau, O.

N1 - Funding Information: We thank F Fava, C Legrand, I Teyssandier, F Lorre, R Tang and Laboratoire Commun de Biologie et Génétique Moléculaires, AP-HP, hôpital Saint-Antoine, Drs D Carp, J Dewulf, S Frederic, L Heuberger, I Leduc, F Lefrere, E Legac, E Ronez, J Roussi, C Salanoubat, J-L Vaerman, M Van Butsel, MD Venon, Professor D Latinne and Professor O Legrand for molecular and clinical biology support. This work was supported by grants from la Ligue contre le Cancer (XC, IP, ES WV and OB, équipe labellisée 2012), from the Agence Nationale de la Recherche (IP, WV ANR Thrombocytosis and GERMPN) and the Laurette Fugain association (WV). XC and OB are supported respectively by grants from the University Paris Diderot and from the ANR. We are grateful for generous support to S.N.C. from the F.R.S.-F.N.R.S., Belgium, the Salus Sanguinis Foundation, the Action de Recherche Concertée ARC10/15-027, the Fondation contre le Cancer, Brussels, and the PAI Program Belgian Medical Genetics Initiative Project P7/43 (BeMG) IAP, Belgium.

PY - 2015/1/10

Y1 - 2015/1/10

UR - http://www.scopus.com/inward/record.url?scp=84920596808&partnerID=8YFLogxK

U2 - 10.1038/leu.2014.270

DO - 10.1038/leu.2014.270

M3 - Letter

C2 - 25212275

AN - SCOPUS:84920596808

SN - 0887-6924

VL - 29

SP - 249

EP - 252

JO - Leukemia

JF - Leukemia

IS - 1

ER -